Asthma exacerbations and worsenings in patients aged 1–75 years with add-on tiotropium treatment

This review explores the effect of tiotropium Respimat® add-on therapy on asthma exacerbations and worsenings, adverse events (AEs) related to exacerbations and symptoms and any effects on seasonality across the 10 UniTinA-asthma® clinical trials comprising over 6000 patients. When added on to inhal...

Descripción completa

Detalles Bibliográficos
Autores principales: Mark FitzGerald, J., Hamelmann, Eckard, Kerstjens, Huib A. M., Buhl, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459309/
https://www.ncbi.nlm.nih.gov/pubmed/32868782
http://dx.doi.org/10.1038/s41533-020-00193-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459309/
https://www.ncbi.nlm.nih.gov/pubmed/32868782
http://dx.doi.org/10.1038/s41533-020-00193-w

Ejemplares similares